Maternal Polyunsaturated Fatty Acids in Association With Child Autism Spectrum Disorder in the MARBLES Study

University of California, Davis252 enrolled

Overview

This study is to examine the association between maternal omega3 and other polyunsaturated fatty acids (PUFAs) during pregnancy and autism spectrum disorder (ASD) as well as other non-typical development (Non-TD) in the prospective Markers of Autism Risk in Babies-Learning Early Signs (MARBLES) cohort.

Study Type

OBSERVATIONAL

Enrollment

252

Conditions

Autism Spectrum Disorder

Interventions

Maternal Supplemental PUFA IntakeBEHAVIORAL

Maternal Supplemental PUFA Intake included sources from the questionnaires and plasma

Eligibility

Sex: ALLMin age: 3 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Mother or father had a biological child with ASD * Mother is at least 18 years old * Mother is pregnant or planning a pregnancy, and biologically able to become pregnant * Mother is living within 2 hours of the MIND Institute * Mother is sufficiently fluent in English Exclusion Criteria: * Mothers with diseases which will influence on their study participation

Outcomes

Primary Outcomes

autism spectrum disorder group (ASD)

number of people with ASD

Time frame: 36 months

Secondary Outcomes

A group of typically development (TD) people

number of typically developed people

Time frame: 36 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.